{"_buckets": {"deposit": "6ae17830-7eba-4eb0-9fa4-e1d71a656cb4"}, "_deposit": {"id": "16300", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "16300"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00016300", "sets": ["456", "1102"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Cytokine Therapy of Renal Cell Cancer"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1998-11", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "11", "bibliographicPageEnd": "692", "bibliographicPageStart": "690", "bibliographicVolumeNumber": "112", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Metastatic renal cell cancer (RCC) is usually treated with immunotherapy using cytokines because it is a mostly chemoresistant malignancy. These therapies are generally based on interleukin-2 (IL-2) or interferon. However, their response rates were less than 20% and various side effects appeared. In order to improve response rate or reduce side effects, we have tried LAK (lymphokine-activated killer cells) therapy and low dose interferon γ therapy. LAK cells are peripheral blood lymphocytes activated in vitro by exposure to IL-2. LAK therapy was done 10 course for 9 patients in our hospital and the overall respones rate was 60%. On the other hand, low dose interferon γ therapy was done for 10 patients and the side effects were relatively small with the response rate of 10%. These results indicate that immunotherapy using cytokines are useful for metastatic renal cancer and its strategy, including dosage, combination therapy, is still to be investigated.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "103950", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Saito, Toshihiro"}]}, {"nameIdentifiers": [{"nameIdentifier": "103951", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Katagiri, Akiyoshi"}]}, {"nameIdentifiers": [{"nameIdentifier": "103952", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Tomiya, Yoshihiko"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "斎藤, 俊弘"}], "nameIdentifiers": [{"nameIdentifier": "103947", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "片桐, 明善"}], "nameIdentifiers": [{"nameIdentifier": "103948", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "冨田, 善彦"}], "nameIdentifiers": [{"nameIdentifier": "103949", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-07"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "112(11)_690-692.pdf", "filesize": [{"value": "523.4 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 523400.0, "url": {"label": "112(11)_690-692.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/16300/files/112(11)_690-692.pdf"}, "version_id": "c263e814-f83f-45c3-8360-19abc4b8397f"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "renal cell cancer", "subitem_subject_scheme": "Other"}, {"subitem_subject": "cytokine therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "interferon", "subitem_subject_scheme": "Other"}, {"subitem_subject": "interleukin-2", "subitem_subject_scheme": "Other"}, {"subitem_subject": "腎細胞癌", "subitem_subject_scheme": "Other"}, {"subitem_subject": "サイトカイン治療", "subitem_subject_scheme": "Other"}, {"subitem_subject": "インターフェロン", "subitem_subject_scheme": "Other"}, {"subitem_subject": "インターロイキン2", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "6)腎細胞癌に対するサイトカイン治療（シンポジウム サイトカインの基礎と臨床応用, 第537回新潟医学会）", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "6)腎細胞癌に対するサイトカイン治療（シンポジウム サイトカインの基礎と臨床応用, 第537回新潟医学会）"}, {"subitem_title": "6)腎細胞癌に対するサイトカイン治療（シンポジウム サイトカインの基礎と臨床応用, 第537回新潟医学会）", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1102"], "permalink_uri": "http://hdl.handle.net/10191/46337", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-02-10"}, "publish_date": "2017-02-10", "publish_status": "0", "recid": "16300", "relation": {}, "relation_version_is_last": true, "title": ["6)腎細胞癌に対するサイトカイン治療（シンポジウム サイトカインの基礎と臨床応用, 第537回新潟医学会）"], "weko_shared_id": null}